ICU Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	301.78	307.96	308.57	254.22	208.78	552.83
Short-Term Investments	-	-	-	1.7	5.55	15.76
Trading Asset Securities	-	3.75	11.04	23.07	28.43	-
Cash & Short-Term Investments	301.78	311.71	319.6	278.98	242.77	568.59
Cash Growth	-0.64%	-2.47%	14.56%	14.92%	-57.30%	37.96%
Accounts Receivable	206.26	180.52	182.83	161.57	221.72	105.89
Other Receivables	-	-	-	2.75	3.55	4.16
Receivables	206.26	180.52	182.83	164.31	225.27	110.05
Inventory	607.27	615.86	584.68	709.36	696.01	290.24
Prepaid Expenses	104.56	32.31	27.6	27.38	37.96	21.07
Other Current Assets	-	50.16	327.28	35.41	29.37	35.62
Total Current Assets	1,220	1,191	1,442	1,221	1,235	1,030
Property, Plant & Equipment	481.16	511.89	499.3	685.53	713.58	510.89
Long-Term Investments	128.93	132.25	8.76	8	57.2	7.86
Goodwill	1,483	1,500	1,433	1,472	1,449	43.44
Other Intangible Assets	536.47	633.56	740.79	870.59	982.77	188.31
Long-Term Deferred Tax Assets	25.44	25.89	24.21	37.3	31.47	42.6
Long-Term Deferred Charges	-	-	-	3.44	5.16	2.83
Other Long-Term Assets	69.16	56.61	56.11	79.88	41.02	55.01
Total Assets	3,944	4,051	4,204	4,378	4,516	1,881

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	142.99	154.37	148.02	150.03	215.9	81.13
Accrued Expenses	342.81	211.21	195.63	152.26	149.66	94.7
Current Portion of Long-Term Debt	18.75	20.26	51	51	29.69	-
Current Portion of Leases	-	15.92	16.76	21.02	18.99	9.65
Current Income Taxes Payable	10.09	10.4	17.33	7.71	6.2	1.45
Current Unearned Revenue	-	33.84	30.36	31.64	30.84	12.65
Other Current Liabilities	-	52.85	97.08	68.18	43.28	1.2
Total Current Liabilities	514.63	498.86	556.18	481.84	494.56	200.78
Long-Term Debt	1,133	1,269	1,532	1,578	1,624	1.48
Long-Term Leases	-	47.68	43.11	54.93	62.77	36.04
Long-Term Unearned Revenue	-	-	-	10.59	16.24	-
Long-Term Deferred Tax Liabilities	8.76	37.76	48.81	55.87	126.01	1.49
Other Long-Term Liabilities	95.89	73.27	58.73	74.04	102.46	24.92
Total Liabilities	1,752	1,927	2,239	2,255	2,426	264.71

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	2.52	2.47	2.45	2.41	2.4	2.13
Additional Paid-In Capital	1,487	1,465	1,412	1,366	1,331	721.41
Retained Earnings	766.96	690.89	690.16	807.85	837.5	911.79
Treasury Stock	-23.04	-0.02	-0.09	-0.26	-0.24	-0.03
Comprehensive Income & Other	-42.17	-34.63	-139.4	-53.08	-80.98	-19.27
Shareholders' Equity	2,191	2,124	1,965	2,123	2,090	1,616
Total Liabilities & Equity	3,944	4,051	4,204	4,378	4,516	1,881

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	1,152	1,353	1,643	1,705	1,735	47.17
Net Cash (Debt)	-850.07	-1,041	-1,323	-1,426	-1,492	521.42
Net Cash Growth	-	-	-	-	-	45.07%
Net Cash Per Share	-33.76	-41.81	-54.25	-59.18	-62.53	23.94
Filing Date Shares Outstanding	25.01	24.69	24.52	24.14	24	23.79
Total Common Shares Outstanding	25.01	24.69	24.52	24.14	23.99	21.28
Working Capital	705.23	691.69	885.8	739.43	740.64	829.03
Book Value Per Share	87.62	86.03	80.16	87.96	87.11	75.94
Tangible Book Value	172.17	-9.49	-208.33	-219.62	-342.1	1,384
Tangible Book Value Per Share	6.88	-0.38	-8.50	-9.10	-14.26	65.05
Land	-	176.97	177.09	278.25	274.06	243.38
Machinery	-	681.57	647.26	725.66	637.1	492.19
Construction In Progress	-	90.75	87.01	117.22	152.91	72.15

SEC Filings: 10-K · 10-Q